NYSE - Delayed Quote USD

Butterfly Network, Inc. (BFLY)

0.9949 -0.0051 (-0.51%)
At close: May 31 at 4:00 PM EDT
0.9980 +0.00 (+0.31%)
After hours: May 31 at 6:40 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
68,080.0000
65,900.0000
73,390.0000
62,565.0000
46,252.0000
Cost of Revenue
50,037.0000
49,044.0000
33,930.0000
45,511.0000
107,475.0000
Gross Profit
18,043.0000
16,856.0000
39,460.0000
17,054.0000
-61,223.0000
Operating Expense
151,227.0000
162,466.0000
232,480.0000
209,782.0000
100,396.0000
Operating Income
-133,184.0000
-145,610.0000
-193,020.0000
-192,728.0000
-161,619.0000
Net Non Operating Interest Income Expense
6,877.0000
7,450.0000
3,382.0000
1,922.0000
-856.0000
Other Income Expense
4,384.0000
4,542.0000
20,957.0000
158,518.0000
-231.0000
Pretax Income
-121,923.0000
-133,618.0000
-168,681.0000
-32,288.0000
-162,706.0000
Tax Provision
-2.0000
82.0000
42.0000
121.0000
39.0000
Net Income Common Stockholders
-121,921.0000
-133,700.0000
-168,723.0000
-32,409.0000
-162,745.0000
Diluted NI Available to Com Stockholders
-121,921.0000
-133,700.0000
-168,723.0000
-32,409.0000
-162,745.0000
Basic EPS
-0.58
-0.65
-0.84
-0.19
-26.87
Diluted EPS
-0.58
-0.65
-0.84
-0.19
-26.87
Basic Average Shares
206,962.4370
205,385.5440
199,848.3860
173,810.0530
6,056.5740
Diluted Average Shares
206,962.4370
205,385.5440
199,848.3860
173,810.0530
6,056.5740
Total Operating Income as Reported
-133,184.0000
-145,610.0000
-193,020.0000
-192,728.0000
-161,619.0000
Total Expenses
201,264.0000
211,510.0000
266,410.0000
255,293.0000
207,871.0000
Net Income from Continuing & Discontinued Operation
-121,921.0000
-133,700.0000
-168,723.0000
-32,409.0000
-162,745.0000
Normalized Income
-126,464.9255
-137,289.7600
-185,201.6100
-150,008.3500
-162,745.0000
Interest Income
7,177.0000
7,450.0000
3,384.0000
2,573.0000
285.0000
Interest Expense
300.0000
--
2.0000
651.0000
1,141.0000
Net Interest Income
6,877.0000
7,450.0000
3,382.0000
1,922.0000
-856.0000
EBIT
-121,623.0000
-133,618.0000
-168,679.0000
-31,637.0000
-161,565.0000
EBITDA
-110,576.0000
-123,044.0000
-162,744.0000
-29,547.0000
-160,249.0000
Reconciled Cost of Revenue
50,037.0000
49,044.0000
33,930.0000
45,511.0000
107,475.0000
Reconciled Depreciation
11,047.0000
10,574.0000
5,935.0000
2,090.0000
1,316.0000
Net Income from Continuing Operation Net Minority Interest
-121,921.0000
-133,700.0000
-168,723.0000
-32,409.0000
-162,745.0000
Total Unusual Items Excluding Goodwill
4,544.0000
4,544.0000
20,859.0000
161,095.0000
--
Total Unusual Items
4,544.0000
4,544.0000
20,859.0000
161,095.0000
--
Normalized EBITDA
-115,120.0000
-127,588.0000
-183,603.0000
-190,642.0000
-160,249.0000
Tax Rate for Calcs
0.0000
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
0.0745
954.2400
4,380.3900
43,495.6500
--
12/31/2020 - 7/13/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HYPR Hyperfine, Inc.
0.8360
-2.86%
 
PACB Pacific Biosciences of California, Inc.
1.7900
-7.73%
 
ASXC Asensus Surgical, Inc.
0.2215
-3.78%
 
CVRX CVRx, Inc.
6.95
+1.02%
 
NNOX Nano-X Imaging Ltd.
8.36
-3.02%
 
BSGM BioSig Technologies, Inc.
2.0100
-0.99%
 
ARAY Accuray Incorporated
1.7700
+12.74%
 
BSX Boston Scientific Corporation
75.57
+0.76%
 
LFWD ReWalk Robotics Ltd.
4.5800
+3.62%
 
BBLG Bone Biologics Corporation
1.6600
+6.41%